ID   PAK2_HUMAN              Reviewed;         524 AA.
AC   Q13177; Q13154; Q6ISC3;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   03-APR-2007, sequence version 3.
DT   05-OCT-2010, entry version 115.
DE   RecName: Full=Serine/threonine-protein kinase PAK 2;
DE            EC=2.7.11.1;
DE   AltName: Full=Gamma-PAK;
DE   AltName: Full=PAK65;
DE   AltName: Full=S6/H4 kinase;
DE   AltName: Full=p21-activated kinase 2;
DE            Short=PAK-2;
DE   AltName: Full=p58;
DE   Contains:
DE     RecName: Full=PAK-2p27;
DE              Short=p27;
DE   Contains:
DE     RecName: Full=PAK-2p34;
DE              Short=p34;
DE     AltName: Full=C-t-PAK2;
GN   Name=PAK2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Sells M., Knause U.J., Bagrodia S., Ambrose D., Bokoch G.M.,
RA   Chernoff J.;
RL   Submitted (APR-1995) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 32-524, AND PROTEIN SEQUENCE OF 401-417.
RC   TISSUE=Placenta;
RX   MEDLINE=95262637; PubMed=7744004;
RA   Martin G.A., Bollag G., McCormick F., Abo A.;
RT   "A novel serine kinase activated by rac1/CDC42Hs-dependent
RT   autophosphorylation is related to PAK65 and STE20.";
RL   EMBO J. 14:1970-1978(1995).
RN   [4]
RP   ERRATUM.
RX   MEDLINE=96016211; PubMed=7556080;
RA   Martin G.A., Bollag G., McCormick F., Abo A.;
RL   EMBO J. 14:4385-4385(1995).
RN   [5]
RP   AUTOPHOSPHORYLATION.
RX   MEDLINE=95403344; PubMed=7673144; DOI=10.1074/jbc.270.36.21121;
RA   Benner G.E., Dennis P.B., Masaracchia R.A.;
RT   "Activation of an S6/H4 kinase (PAK 65) from human placenta by
RT   intramolecular and intermolecular autophosphorylation.";
RL   J. Biol. Chem. 270:21121-21128(1995).
RN   [6]
RP   CASPASE-3 CLEAVAGE AT ASP-512, FUNCTION, AND MUTAGENESIS OF ASP-212.
RX   PubMed=9171063; DOI=10.1126/science.276.5318.1571;
RA   Rudel T., Bokoch G.M.;
RT   "Membrane and morphological changes in apoptotic cells regulated by
RT   caspase-mediated activation of PAK2.";
RL   Science 276:1571-1574(1997).
RN   [7]
RP   CASPASE-3 CLEAVAGE AT ASP-512, AUTOPHOSPHORYLATION, AND MUTAGENESIS OF
RP   LYS-278 AND THR-402.
RX   PubMed=9786869; DOI=10.1074/jbc.273.44.28733;
RA   Walter B.N., Huang Z., Jakobi R., Tuazon P.T., Alnemri E.S.,
RA   Litwack G., Traugh J.A.;
RT   "Cleavage and activation of p21-activated protein kinase gamma-PAK by
RT   CPP32 (caspase 3). Effects of autophosphorylation on activity.";
RL   J. Biol. Chem. 273:28733-28739(1998).
RN   [8]
RP   INTERACTION WITH HIV-1 NEF.
RX   MEDLINE=20523903; PubMed=11070003;
RX   DOI=10.1128/JVI.74.23.11081-11087.2000;
RA   Arora V.K., Molina R.P., Foster J.L., Blakemore J.L., Chernoff J.,
RA   Fredericksen B.L., Garcia J.V.;
RT   "Lentivirus Nef specifically activates Pak2.";
RL   J. Virol. 74:11081-11087(2000).
RN   [9]
RP   FUNCTION (PAK-2P34), UBIQUITINATION, SUBCELLULAR LOCATION, AND
RP   MUTAGENESIS OF 239-ILE--GLY-243 AND 246-LYS--LYS-248.
RX   PubMed=12853446; DOI=10.1074/jbc.M306494200;
RA   Jakobi R., McCarthy C.C., Koeppel M.A., Stringer D.K.;
RT   "Caspase-activated PAK-2 is regulated by subcellular targeting and
RT   proteasomal degradation.";
RL   J. Biol. Chem. 278:38675-38685(2003).
RN   [10]
RP   INTERACTION WITH ARHGAP10, AND SUBCELLULAR LOCATION.
RX   PubMed=15471851; DOI=10.1074/jbc.M410530200;
RA   Koeppel M.A., McCarthy C.C., Moertl E., Jakobi R.;
RT   "Identification and characterization of PS-GAP as a novel regulator of
RT   caspase-activated PAK-2.";
RL   J. Biol. Chem. 279:53653-53664(2004).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2; SER-141 AND THR-143,
RP   AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [12]
RP   INTERACTION WITH SH3MD4.
RX   PubMed=16374509; DOI=10.1038/sj.embor.7400596;
RA   Kaerkkaeinen S., Hiipakka M., Wang J.-H., Kleino I.,
RA   Vaehae-Jaakkola M., Renkema G.H., Liss M., Wagner R., Saksela K.;
RT   "Identification of preferred protein interactions by phage-display of
RT   the human Src homology-3 proteome.";
RL   EMBO Rep. 7:186-191(2006).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-141, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [14]
RP   FUNCTION (PAK-2P34), MYRISTOYLATION AT GLY-213 (PAK-2P34), AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=16617111; DOI=10.1073/pnas.0600824103;
RA   Vilas G.L., Corvi M.M., Plummer G.J., Seime A.M., Lambkin G.R.,
RA   Berthiaume L.G.;
RT   "Posttranslational myristoylation of caspase-activated p21-activated
RT   protein kinase 2 (PAK2) potentiates late apoptotic events.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:6542-6547(2006).
RN   [15]
RP   INTERACTION WITH SCRIB.
RX   PubMed=18716323; DOI=10.1093/hmg/ddn248;
RA   Nola S., Sebbagh M., Marchetto S., Osmani N., Nourry C., Audebert S.,
RA   Navarro C., Rachel R., Montcouquiol M., Sans N.,
RA   Etienne-Manneville S., Borg J.-P., Santoni M.-J.;
RT   "Scrib regulates PAK activity during the cell migration process.";
RL   Hum. Mol. Genet. 17:3552-3565(2008).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-60, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-58; SER-141 AND THR-169,
RP   AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RA   Colinge J., Superti-Furga G., Bennett K.L.;
RL   Submitted (OCT-2008) to UniProtKB.
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-58 AND SER-141, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-55; SER-141; THR-143 AND
RP   SER-197, AND MASS SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [21]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-38 AND LYS-128, AND MASS
RP   SPECTROMETRY.
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
CC   -!- FUNCTION: The activated kinase acts on a variety of targets.
CC       Phosphorylates ribosomal protein S6, histone H4 and myelin basic
CC       protein. Full length PAK 2 stimulates cell survival and cell
CC       growth. The process is, at least in part, mediated by
CC       phosphorylation and inhibition of pro-apoptotic BAD. Caspase-
CC       activated PAK-2p34 is involved in cell death response, probably
CC       involving the JNK signaling pathway. Cleaved PAK-2p34 seems to
CC       have a higher activity than the CDC42-activated form.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- ENZYME REGULATION: Activated by binding small G proteins. Binding
CC       of GTP-bound CDC42 or RAC1 to the autoregulatory region releases
CC       monomers from the autoinhibited dimer, enables phosphorylation of
CC       Thr-402 and allows the kinase domain to adopt an active structure
CC       (By similarity). Following caspase cleavage, autophosphorylted
CC       PAK-2p34 is constitutively active.
CC   -!- SUBUNIT: Interacts tightly with GTP-bound but not GDP-bound
CC       CDC42/p21 and RAC1. Interacts with SH3MD4. Interacts with and
CC       activated by HIV-1 Nef. PAK-2p34 interacts with ARHGAP10.
CC       Interacts with SCRIB.
CC   -!- INTERACTION:
CC       Self; NbExp=2; IntAct=EBI-1045887, EBI-1045887;
CC       Q9Y2X7:GIT1; NbExp=1; IntAct=EBI-1045887, EBI-466061;
CC       Q14161:GIT2; NbExp=1; IntAct=EBI-1045887, EBI-1046878;
CC       P53667:LIMK1; NbExp=2; IntAct=EBI-1045887, EBI-444403;
CC       P25205:MCM3; NbExp=1; IntAct=EBI-1045887, EBI-355153;
CC       P35580:MYH10; NbExp=1; IntAct=EBI-1045887, EBI-351758;
CC       P04049:RAF1; NbExp=2; IntAct=EBI-1045887, EBI-365996;
CC   -!- SUBCELLULAR LOCATION: Serine/threonine-protein kinase PAK 2:
CC       Cytoplasm.
CC   -!- SUBCELLULAR LOCATION: PAK-2p34: Nucleus. Cytoplasm, perinuclear
CC       region. Membrane; Lipid-anchor. Note=Interaction with ARHGAP10
CC       probably changes PAK-2p34 location to cytoplasmic perinuclear
CC       region. Myristoylation changes PAK-2p34 location to the membrane.
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed. Higher levels seen in
CC       skeletal muscle, ovary, thymus and spleen.
CC   -!- PTM: Full length PAK 2 is autophosphorylated when activated by
CC       CDC42/p21. Following cleavage, both peptides, PAK-2p27 and PAK-
CC       2p34, become highly autophosphorylated, with PAK-2p27 being
CC       phosphorylated on serine and PAK-2p34 on threonine residues,
CC       respectively. Autophosphorylation of PAK-2p27 can occur in the
CC       absence of any effectors and is dependent on phosphorylation of
CC       Thr-402, because PAK-2p27 is acting as an exogenous substrate.
CC   -!- PTM: During apoptosis proteolytically cleaved by caspase-3 or
CC       caspase-3-like proteases to yield active PAK-2p34.
CC   -!- PTM: Ubiquitinated, leading to its proteosomal degradation.
CC   -!- PTM: PAK-2p34 is myristoylated.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. STE Ser/Thr
CC       protein kinase family. STE20 subfamily.
CC   -!- SIMILARITY: Contains 1 CRIB domain.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U24153; AAA65442.1; -; mRNA.
DR   EMBL; BC069613; AAH69613.1; -; mRNA.
DR   EMBL; U25975; AAA75468.1; -; mRNA.
DR   IPI; IPI00419979; -.
DR   PIR; S58682; S58682.
DR   RefSeq; NP_002568.2; -.
DR   UniGene; Hs.518530; -.
DR   ProteinModelPortal; Q13177; -.
DR   SMR; Q13177; 77-143, 228-519.
DR   DIP; DIP-38249N; -.
DR   IntAct; Q13177; 49.
DR   MINT; MINT-235655; -.
DR   STRING; Q13177; -.
DR   PhosphoSite; Q13177; -.
DR   OGP; Q13177; -.
DR   PRIDE; Q13177; -.
DR   Ensembl; ENST00000327134; ENSP00000314067; ENSG00000180370.
DR   GeneID; 5062; -.
DR   KEGG; hsa:5062; -.
DR   UCSC; uc003fwy.2; human.
DR   CTD; 5062; -.
DR   GeneCards; GC03P196466; -.
DR   H-InvDB; HIX0030815; -.
DR   HGNC; HGNC:8591; PAK2.
DR   HPA; CAB007794; -.
DR   MIM; 605022; gene.
DR   PharmGKB; PA32918; -.
DR   eggNOG; prNOG08571; -.
DR   HOGENOM; HBG755340; -.
DR   HOVERGEN; HBG108518; -.
DR   InParanoid; Q13177; -.
DR   OMA; FLDSYLM; -.
DR   OrthoDB; EOG96MF4W; -.
DR   PhylomeDB; Q13177; -.
DR   BRENDA; 2.7.11.1; 247.
DR   Pathway_Interaction_DB; faspathway; FAS signaling pathway (CD95).
DR   Pathway_Interaction_DB; fcer1pathway; Fc-epsilon receptor I signaling in mast cells.
DR   Pathway_Interaction_DB; p38alphabetapathway; Regulation of p38-alpha and p38-beta.
DR   Reactome; REACT_18266; Axon guidance.
DR   Reactome; REACT_578; Apoptosis.
DR   Reactome; REACT_6185; HIV Infection.
DR   Reactome; REACT_6900; Signaling in Immune system.
DR   NextBio; 19496; -.
DR   PMAP-CutDB; Q13177; -.
DR   ArrayExpress; Q13177; -.
DR   Bgee; Q13177; -.
DR   CleanEx; HS_PAK2; -.
DR   Genevestigator; Q13177; -.
DR   GermOnline; ENSG00000180370; Homo sapiens.
DR   GO; GO:0005829; C:cytosol; EXP:Reactome.
DR   GO; GO:0016020; C:membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:MGI.
DR   GO; GO:0006915; P:apoptosis; IEA:UniProtKB-KW.
DR   GO; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW.
DR   GO; GO:0006469; P:negative regulation of protein kinase activity; TAS:ProtInc.
DR   GO; GO:0046777; P:protein amino acid autophosphorylation; IDA:MGI.
DR   GO; GO:0040008; P:regulation of growth; IEA:UniProtKB-KW.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000095; PAK_box_Rho-bd.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR015750; Ser/Thr_kinase_Pak-rel.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   InterPro; IPR002290; Ser/Thr_prot_kinase_dom.
DR   PANTHER; PTHR22986:SF84; Pak_like; 1.
DR   Pfam; PF00786; PBD; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00285; PBD; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS50108; CRIB; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Allosteric enzyme; Apoptosis; ATP-binding;
KW   Complete proteome; Cytoplasm; Direct protein sequencing;
KW   Growth regulation; Host-virus interaction; Kinase; Lipoprotein;
KW   Membrane; Myristate; Nucleotide-binding; Nucleus; Phosphoprotein;
KW   Serine/threonine-protein kinase; Transferase; Ubl conjugation.
FT   CHAIN         1    524       Serine/threonine-protein kinase PAK 2.
FT                                /FTId=PRO_0000086465.
FT   CHAIN         1    212       PAK-2p27.
FT                                /FTId=PRO_0000304922.
FT   CHAIN       213    524       PAK-2p34.
FT                                /FTId=PRO_0000304923.
FT   DOMAIN       74     87       CRIB.
FT   DOMAIN      249    499       Protein kinase.
FT   NP_BIND     255    263       ATP (By similarity).
FT   REGION       69    137       Autoregulatory region (By similarity).
FT   REGION       69    112       GTPase-binding (By similarity).
FT   MOTIF       245    251       Nuclear localization signal.
FT   ACT_SITE    367    367       Proton acceptor (By similarity).
FT   BINDING     278    278       ATP (By similarity).
FT   SITE        212    213       Cleavage; by caspase-3 or caspase-3-like
FT                                proteases.
FT   MOD_RES       2      2       Phosphoserine.
FT   MOD_RES      38     38       N6-acetyllysine.
FT   MOD_RES      55     55       Phosphoserine.
FT   MOD_RES      58     58       Phosphoserine.
FT   MOD_RES      60     60       Phosphothreonine.
FT   MOD_RES     128    128       N6-acetyllysine.
FT   MOD_RES     139    139       Phosphotyrosine (By similarity).
FT   MOD_RES     141    141       Phosphoserine.
FT   MOD_RES     143    143       Phosphothreonine.
FT   MOD_RES     169    169       Phosphothreonine.
FT   MOD_RES     197    197       Phosphoserine.
FT   MOD_RES     402    402       Phosphothreonine; by autocatalysis
FT                                (Probable).
FT   LIPID       213    213       N-myristoyl glycine.
FT   MUTAGEN     212    212       D->N: Inhibits caspase-mediated cleavage.
FT   MUTAGEN     213    213       G->A: Abolishes myristoylation of PAK-
FT                                2p34 and membrane location.
FT   MUTAGEN     239    243       IVSIG->REGRS: Abolishes nuclear export.
FT   MUTAGEN     246    248       KKK->MHE: Greatly inhibits nuclear
FT                                localization.
FT   MUTAGEN     278    278       K->R: Abolishes kinase activity and
FT                                autophosphorylation.
FT   MUTAGEN     402    402       T->A: Abolishes kinase activity and
FT                                greatly inhibits autophosphorylation of
FT                                PAK-2p27 and PAK-2p34.
FT   CONFLICT     90     90       A -> T (in Ref. 3; AAA75468).
FT   CONFLICT    150    150       F -> L (in Ref. 1; AAA65442).
FT   CONFLICT    225    225       T -> P (in Ref. 1; AAA65442).
FT   CONFLICT    258    258       G -> R (in Ref. 2; AAH69613).
FT   CONFLICT    329    329       G -> R (in Ref. 3; AAA75468).
FT   CONFLICT    338    338       T -> TA (in Ref. 1; AAA65442).
SQ   SEQUENCE   524 AA;  58043 MW;  00A7CD15F93D4180 CRC64;
     MSDNGELEDK PPAPPVRMSS TIFSTGGKDP LSANHSLKPL PSVPEEKKPR HKIISIFSGT
     EKGSKKKEKE RPEISPPSDF EHTIHVGFDA VTGEFTGMPE QWARLLQTSN ITKLEQKKNP
     QAVLDVLKFY DSNTVKQKYL SFTPPEKDGF PSGTPALNAK GTEAPAVVTE EEDDDEETAP
     PVIAPRPDHT KSIYTRSVID PVPAPVGDSH VDGAAKSLDK QKKKTKMTDE EIMEKLRTIV
     SIGDPKKKYT RYEKIGQGAS GTVFTATDVA LGQEVAIKQI NLQKQPKKEL IINEILVMKE
     LKNPNIVNFL DSYLVGDELF VVMEYLAGGS LTDVVTETCM DEAQIAAVCR ECLQALEFLH
     ANQVIHRDIK SDNVLLGMEG SVKLTDFGFC AQITPEQSKR STMVGTPYWM APEVVTRKAY
     GPKVDIWSLG IMAIEMVEGE PPYLNENPLR ALYLIATNGT PELQNPEKLS PIFRDFLNRC
     LEMDVEKRGS AKELLQHPFL KLAKPLSSLT PLIMAAKEAM KSNR
//
